Jin Medical International Stock Alpha and Beta Analysis

ZJYL Stock   0.98  0.10  11.36%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as JIN MEDICAL INTERNATIONAL. It also helps investors analyze the systematic and unsystematic risks associated with investing in JIN MEDICAL over a specified time horizon. Remember, high JIN MEDICAL's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to JIN MEDICAL's market risk premium analysis include:
Beta
1.71
Alpha
(1.45)
Risk
9.3
Sharpe Ratio
(0.13)
Expected Return
(1.23)
Please note that although JIN MEDICAL alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, JIN MEDICAL did 1.45  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of JIN MEDICAL INTERNATIONAL stock's relative risk over its benchmark. JIN MEDICAL INTERNATIONAL has a beta of 1.71  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, JIN MEDICAL will likely underperform. At this time, JIN MEDICAL's Book Value Per Share is quite stable compared to the past year. Tangible Book Value Per Share is expected to rise to 3.10 this year, although Enterprise Value Over EBITDA will most likely fall to 2.00.

Enterprise Value

6.2 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out JIN MEDICAL Backtesting, JIN MEDICAL Valuation, JIN MEDICAL Correlation, JIN MEDICAL Hype Analysis, JIN MEDICAL Volatility, JIN MEDICAL History and analyze JIN MEDICAL Performance.

JIN MEDICAL Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. JIN MEDICAL market risk premium is the additional return an investor will receive from holding JIN MEDICAL long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in JIN MEDICAL. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate JIN MEDICAL's performance over market.
α-1.45   β1.71

JIN MEDICAL expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of JIN MEDICAL's Buy-and-hold return. Our buy-and-hold chart shows how JIN MEDICAL performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

JIN MEDICAL Market Price Analysis

Market price analysis indicators help investors to evaluate how JIN MEDICAL stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading JIN MEDICAL shares will generate the highest return on investment. By understating and applying JIN MEDICAL stock market price indicators, traders can identify JIN MEDICAL position entry and exit signals to maximize returns.

JIN MEDICAL Return and Market Media

The median price of JIN MEDICAL for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 is 2.51 with a coefficient of variation of 27.76. The daily time series for the period is distributed with a sample standard deviation of 0.62, arithmetic mean of 2.25, and mean deviation of 0.49. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Analyzing Jin Medical International and Milestone Scientific
09/30/2024
2
ZJYL Stock Dips 5.60 percent Amid Lack of Institutional Ratings
10/09/2024
3
ZJYL Stock Declines Amidst Broader Medical Device Sector Downturn
10/23/2024
4
Jin Medical International Ltd.s 27 percent Dip Still Leaving Some Shareholders Feeling Restless Over Its PSRatio
10/30/2024
5
Jin Medical International Ltd. Stocks Been Sliding But Fundamentals Look Decent Will The Market Correct The Share Price In The Future
11/19/2024

About JIN MEDICAL Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including JIN or other stocks. Alpha measures the amount that position in JIN MEDICAL INTERNATIONAL has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2022 2023 2024 (projected)
Days Sales Outstanding80.87156.53180.01142.82
PTB Ratio0.210.350.410.39
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards JIN MEDICAL in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, JIN MEDICAL's short interest history, or implied volatility extrapolated from JIN MEDICAL options trading.

Build Portfolio with JIN MEDICAL

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether JIN MEDICAL INTERNATIONAL is a strong investment it is important to analyze JIN MEDICAL's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact JIN MEDICAL's future performance. For an informed investment choice regarding JIN Stock, refer to the following important reports:
JIN MEDICAL technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of JIN MEDICAL technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of JIN MEDICAL trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...